Edwards Lifesciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	39,296	42,134	42,174	41,838	43,162	71,120
Market Cap Growth	-3.73%	-0.10%	0.80%	-3.07%	-39.31%	53.01%
Enterprise Value	36,624	39,453	38,619	40,840	42,178	70,143
Last Close Price	67.65	73.42	72.02	69.00	70.10	115.55
PE Ratio	42.98	46.08	10.46	32.98	30.31	53.81
PS Ratio	7.60	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.52	4.85	4.34	6.88	7.94	13.86
P/TBV Ratio	6.32	6.77	6.20	9.06	10.59	18.62
P/FCF Ratio	-	-	150.61	71.94	47.38	57.51
P/OCF Ratio	-	-	80.51	51.63	37.87	46.70
EV/Sales Ratio	7.11	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	24.13	25.91	24.44	27.66	26.81	46.34
EV/EBIT Ratio	26.37	28.31	27.00	30.35	29.24	50.28
EV/FCF Ratio	-	-	137.92	70.23	46.30	56.73
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.39	0.39	0.42	0.41	0.40	0.39
Debt / FCF Ratio	-	-	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.31	-0.31	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.76	-1.76	-2.01	-0.58	-0.31	-0.45
Net Debt / FCF Ratio	-	-	-11.32	-1.47	-0.54	-0.55
Asset Turnover	-	-	0.49	0.57	0.53	0.67
Inventory Turnover	-	-	1.12	1.10	0.90	1.63
Quick Ratio	-	-	3.13	2.06	1.87	2.07
Current Ratio	-	-	4.18	3.38	3.03	3.08
Return on Equity (ROE)	10.42%	10.42%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	-	-	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	19.22%	19.60%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	-	-	12.80%	18.20%	21.20%	21.20%
Earnings Yield	2.33%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	-	-	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	2.25%	2.25%	1.66%	2.37%	1.11%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.